245 related articles for article (PubMed ID: 31507233)
1. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
[No Abstract] [Full Text] [Related]
2. Precision medicine in breast cancer.
Naito Y; Urasaki T
Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
[TBL] [Abstract][Full Text] [Related]
3. Genetic heterogeneity in breast cancer: the road to personalized medicine?
Baird RD; Caldas C
BMC Med; 2013 Jun; 11():151. PubMed ID: 23800221
[TBL] [Abstract][Full Text] [Related]
4. Precision Medicine in Breast Cancer.
Odle TG
Radiol Technol; 2017 Mar; 88(4):401M-421M. PubMed ID: 28298516
[TBL] [Abstract][Full Text] [Related]
5. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.
Aleskandarany MA; Vandenberghe ME; MarchiĆ² C; Ellis IO; Sapino A; Rakha EA
Pathobiology; 2018; 85(1-2):23-34. PubMed ID: 29428954
[TBL] [Abstract][Full Text] [Related]
6. Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology.
Ziogas DE; Kyrochristos ID; Roukos DH
Drug Discov Today; 2018 Nov; 23(11):1848-1872. PubMed ID: 30077778
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the genomic profile for personalized breast cancer treatment: POLAR study].
Cieslak AM; Sonnhoff MA
Strahlenther Onkol; 2024 Jul; 200(7):652-654. PubMed ID: 38743274
[No Abstract] [Full Text] [Related]
8. Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy.
Kyrochristos ID; Ziogas DE; Roukos DH
Drug Discov Today; 2019 Jun; 24(6):1281-1294. PubMed ID: 31009757
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.
Smith B; Agarwal P; Bhowmick NA
Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080
[TBL] [Abstract][Full Text] [Related]
10. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
Andre F; Vicier C; Delaloge S
Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
[TBL] [Abstract][Full Text] [Related]
11. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
[TBL] [Abstract][Full Text] [Related]
12. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
[TBL] [Abstract][Full Text] [Related]
13. Adaptive treatments show promise in breast cancer.
Baker H
Lancet Oncol; 2016 Aug; 17(8):e327. PubMed ID: 27425815
[No Abstract] [Full Text] [Related]
14. Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway Analysis.
Wu T; Wang X; Li J; Song X; Wang Y; Wang Y; Zhang L; Li Z; Tian J
PLoS One; 2015; 10(6):e0131183. PubMed ID: 26126114
[TBL] [Abstract][Full Text] [Related]
15. Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.
Fayanju OM; Park KU; Lucci A
Ann Surg Oncol; 2018 Feb; 25(2):512-519. PubMed ID: 29159748
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer genome analysis in time and space: biomarker development strategy.
Kyrochristos ID; Ziogas DE; Lykoudis EG; Roukos DH
Biomark Med; 2018 Jun; 12(6):547-550. PubMed ID: 29873520
[No Abstract] [Full Text] [Related]
17. Breast cancer and genomic testing.
Liedtke C; Kolberg HC
Br J Surg; 2017 Jun; 104(7):799-801. PubMed ID: 28300277
[No Abstract] [Full Text] [Related]
18. Dynamic genome and transcriptional network-based biomarkers and drugs: precision in breast cancer therapy.
Kyrochristos ID; Ziogas DE; Roukos DH
Med Res Rev; 2019 May; 39(3):1205-1227. PubMed ID: 30417574
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.
Eke I; Makinde AY; Aryankalayil MJ; Ahmed MM; Coleman CN
Cancer Lett; 2016 Nov; 382(1):118-126. PubMed ID: 26828133
[TBL] [Abstract][Full Text] [Related]
20. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]